Bio-S
30109637.965.56% ( +2.00 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Bio-S(301096) the Revenue is 160.46 M (+24.65%);the EBIT is 11.95 M (+147.1%);the EPS is 0.118 (+149.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.16B24.65%
----
----
EBIT
0.01B147.10%
----
----
EPS
0.1181149.21%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf